GRA_Logo

 + Home + About Us + Contact Us
 
+ Drug Delivery   + Monitoring & Diagnostics   + Healthcare    + Therapeutics    + Wound Care
 
Drug Cartridge-based Syringes & Injectors
Devices, Therapeutics, Players, Markets and Prospects


About This Report

Price: US$3,850

Publication: April 2011

Product Code: CBJ646F




In the past two decades, drug delivery has become a major factor in the advancement of the quality of life and a key factor in the business success of pharmaceutical companies. During this time, syringes and injectors have evolved considerable to address the changing demands of clinicians and their patients. In particular, the appearance and refinement of disposable drug cartridges has created unique opportunities for developers of injectable drugs. Prefilled cartridges offer several advantages over traditional packaging in vials. For single dose devices, prefilled cartridges contain the exact deliverable dose desired. The custom of overfilling vials to insure availability of the desired dose allows for the possibility of dosing errors that are eliminated with cartridge systems. For recombinant drugs that have an extremely high cost per dose, the economics associated with exact filling are compelling. 
Highlights

· Provides detailed analysis of cartridge-based syringe and injector market segments, market dynamics and market demographics

· Analyzes therapeutic demand drivers and evaluates commercial cartridge-based syringe and injector products in eleven major therapeutic segments

· Examines design factors, material selection issues, technologies and market development issues

· Charts product data and forecasts to 2015

· Profiles market participants, their product development activities, business strategies, and corporate alliances and affiliations
Table of Contents
Executive Summary

Injectable Drug Market Dynamics
  The Injectable Drug Ecosystem
  Drug Class, Indications and Demand
  Specialty Injection Device Demand Drivers
    Chronic Conditions and Self-Administration
    Shifting Patient Demographics
    Drug Economics, Safety and Compliance
    Biosimilars and Injectable Generics
  Competitive Landscape
  Technology Market Drivers

Cartridge System Design Factors
  Standard Device Platforms
  Single Dose vs. Multi-Dose Devices
  Disposable Devices
  Reusable Devices
  Lyophilized Drugs & Dual Chamber Cartridges

Cartridge-based Injectables - Product Analysis
  Anticoagulants
  Anticonvulsants
  Antiemetics
  Antihistamines & Catecholamines
  Antivirals
  Bnzodiazepines
  Beta Blockers
  Dopamine Agonists
  Growth Hormones
  Hematopoietics
  Incretin Mimetics
  Insulins
  NSAIDs
  Parathyroid Hormones
  Narcotic Analgesics
  Opioid Antagonists
  Reproductive Hormones
  Triptans

Cartridge-based Injectables - Market Sector Assessments and Forecasts
  Cardiovascular
  Immunology
  Metabolic
    Diabetes
    Hormone Deficiency
    Osteoporosis
  Neurology
    Epilepsy
    Migraine
    Pain Management
    Parkinson’s Disease
 Reproductive Medicine

Market Factors
  Regulatory Considerations
  Patient Preferences
  Strategic Alliances & Partnerships

Market Participant Profiles




 

 

Recent Research

Prefilled Syringes to 2016

Drug Self-Administration Markets to 2016

Therapeutic Proteins to 2016


Events

American Association for Clinical Chemistry (July 2012)

World Congress on Glucose Monitoring and Insulin Delivery (April 2012)

 
     
 
Greystone Research Associates
98 Route 101A, Suite 17
Amherst, NH 03031 USA

Phone: 603-595-4340/ Fax: 603-218-7020
Copyright 2011 ·  Greystone Research Associates  ·  All Rights Reserved · Conditions of Use  ·  Career